CS Paper Radar

The Ceiling Is in the Channel: Auditing Learner Gaps and Measurement Frontiers in Clinical Prediction

Sayeed Shafayet Chowdhury, Nusrat Jahan, Snehasis Mukhopadhyay, Shiaofen Fang, Vijay R. Ramakrishnan

cs.AI ·submitted 2026-09-01 22:15 UTC · v1

Abstract

Clinical prediction can saturate for two different reasons: a fitted learner may fail to extract available information, or the recorded variables may impose a population frontier. We separate these quantities through the \emph{learner gap} and the \emph{measurement-channel ceiling}. Optimal balanced accuracy is characterized by total-variation separation, yielding architecture invariance, a sharp partial-identification result under replacement contamination, a cross-fitted ceiling estimator, and exact conditions for multimodal decision improvement. We add two finite-sample diagnostics, namely a label-permutation optimism floor and an underfit curve, and validate the audit on three real cohorts: UCI readmission ($n=99{,}343$), BRFSS diabetes ($n=253{,}680$), and NHANES HbA1c ($n=10{,}219$). Well-tuned gradient boosting nearly reaches the estimated frontier in UCI and BRFSS, whereas deliberately or practically deficient learners retain large gaps. NHANES yields a null difference between questionnaire and measured marginal frontiers but a significant joint complementarity gain, refining the simplistic claim that an objective modality must dominate. Across all cohorts, modest AUROC gains coexist with substantially larger Bayes decision-flip rates, and several architectures estimate similar frontiers while their achieved balanced accuracy differs sharply. A PRISMA-guided synthesis of 104 clinical tasks then shows that the same channel-level regularities recur across more than 18 disease categories: a broad but non-universal structured-clinical region, diminishing same-channel gains across model families, and higher performance when measurement channels change. The framework converts saturation from an empirical observation into an auditable decision: improve the learner when headroom remains; improve measurement when it does not.

Closest papers

Nearest neighbours by meaning across the whole index.

Repeated-Measure Leakage, Distribution Shift, and Reliability under Partial Observation in Patient World Models

cs.LG ·2026-10-03 ·Arjun Subramanian
publishedcode/data similarity 0.64
Abstract · 13 pages, 7 figures. Selected for oral presentation at the NeurIPS 2026 Workshop on World Models for High-Stakes Health (WMHS) Replication P…

Patient world models are increasingly proposed for longitudinal prediction, intervention-aware reasoning, and clinical-trial simulation. Causal or clinical intervention validity is distinct from predictive generalization and reliability; before making stronger claims, the underlying predictive state should generalize across patients, survive realistic shifts and missing observations, and expose failure through meaningful reliability signals. We evaluate these prerequisites in a deliberately narrow setting: short-horizon digital-biomarker forecasting from PhysioNet GaitPDB, comprising 165 participants, 306 recordings, and 51,129 context-future pairs. Using persistence, ridge, MLP, GRU, Transformer, and a compact JEPA-style predictor, we build an evaluation ladder that progressively removes raw temporal overlap, same-recording familiarity, and same-patient familiarity before testing unseen-patient generalization. For GRU, NMSE rises from 0.1227 under random-window splitting to 0.1393 after eliminating raw train-test overlap and to 0.1961 under patient holdout. Among 54 participants with repeated recordings, exposure to a different recording from the same patient improves GRU NMSE from 0.2177 to 0.1556, while a recording-excluded identity hypothesis is not supported at the participant level. Under participant-held-out evaluation, MLP and Transformer are statistically indistinguishable. Study shift, a four-times-longer prediction gap, and partial observation further degrade performance; under 50% temporal masking, Transformer NMSE rises to 0.611 while MC-dropout predictive variance falls. We do not claim a longitudinal or intervention-aware simulator. Instead, the results support a prerequisite evaluation stack of patient separation, repeated-measure controls, shift, missingness, and uncertainty validation before stronger patient-world-model claims are trusted.

0.39

When Copying Is Hard to Beat: A Negative Result in Clinical Assessment Forecasting

cs.LG ·2026-11-13 ·Marius Fracarolli, Stefan Riezler
published similarity 0.63
Abstract · Accepted at FMTS (Foundation Models for Temporal Systems), a workshop at NeurIPS 2026, Sydney

We report a negative result in next-day clinical assessment forecasting: the evaluated models show no consistent advantage over strong persistence-based baselines. Clinicians can view the previous day's questionnaire answers, a plausible source of documentation persistence. Predicting 45 items on 29,715 ICU day-pairs with patient-disjoint splits, a physiology-informed gated model improves item-macro-F1 over a one-line clinical rule by +0.0019 [+0.0006,+0.0031], while losing accuracy. No macro-F1 advantage is established when the physiology window ends at the previous form's reference time (+0.0001 [-0.0006,+0.0008]), or when scoring excludes the 68.5% of cells derived from parent answers; combining both changes yields a small disadvantage. Four checkpoints across three families underperform persistence, and a fine-tuned one differs from it on only two cells. A categorical read-out raises changed-cell accuracy eightfold, but a state-only read-out scores higher overall than forecast-only decoding and matches a transition matrix. This negative result highlights how the documentation process, input cutoff, observation mask and decoding rule shape conclusions about forecasting recorded assessments.

0.43

Kolmogorov-Arnold Networks vs. Multi-Layer Perceptrons: A Rigorous Statistical Benchmark on Clinical Tabular Data

cs.LG cs.AI ·2026-11-02 ·Rafał Wodziński, Paweł Szczerbiak
benchmarkcode/data similarity 0.62
Abstract · 18 pages, 9 figures, 6 tables

Kolmogorov-Arnold Networks (KANs) have recently been proposed as a promising alternative to Multi-Layer Perceptrons (MLPs). However, empirical evaluations on structured medical datasets remain scarce, and commonly reported metrics like AUROC can yield overly optimistic performance estimates on imbalanced clinical cohorts. In this study, we present a standardized benchmark comparing eleven architectures - nine KAN variants (FastKAN, WavKAN, ReLUKAN, ChebyKAN, TaylorKAN, GramKAN, JacobiKAN, LegendreKAN, and TabKAN), a tuned StandardMLP, and a Random Forest baseline - across seven heterogeneous medical tabular datasets spanning oncology, cardiology, nephrology, neurology, endocrinology, and obstetrics. Our experimental protocol employs a 3x5 Repeated Stratified K-Fold cross-validation scheme with nested Bayesian hyperparameter optimization and evaluates discrimination via Area Under the Precision-Recall Curve (AUPRC), calibration through the Brier Score, and computational efficiency. Formal equivalence testing is conducted using the Bayesian Correlated t-Test with a Region of Practical Equivalence (ROPE) at +/- 0.01. The results indicate that on datasets with severe class imbalance, dedicated KAN architectures (particularly TabKAN and ReLUKAN) can improve minority-class detection and achieve higher AUPRC than standard MLPs. Nevertheless, across pooled datasets, KAN variants demonstrate comparable overall predictive discrimination rather than a systematic advantage, while requiring 1.20x to 1.48x longer inference latency per sample and up to 12.5x more trainable parameters. Consequently, StandardMLP remains a strong baseline on the efficiency Pareto frontier, while KAN variants provide a viable alternative when precision on rare positive cases is the primary clinical objective. The code for reproducing the results is available at https://github.com/rafalwodzinski/kan_mlp_comparison.

0.31

Diagnosing Low-Confidence Patient Profiles via Localized Harmful Covariate Shift Detection

cs.LG cs.AI ·2026-10-13 ·Olivier Lefebvre, Hakima Laribi, Dan Poenaru, Martin Vallières
publishedcode/data similarity 0.62
Abstract · Accepted at SMASH (Symposium on Machine Learning and Applications in Healthcare) 2026. Code available at https://github.com/MEDomicsLab/stud…

Before deploying clinical prediction models, their reliability must be assessed to ensure safe use. Errors may arise from distribution shifts between training and deployment or from heterogeneous performance where the model systematically underperforms for certain patient subgroups. Yet most post-hoc diagnostic methods evaluate reliability only at the population level, checking whether the deployment data resemble the training data and whether the model performs well on average, without accounting for heterogeneity that may cause some patients to be disproportionately affected. We propose a unified diagnostic pipeline that combines both perspectives. MED3pa first discovers interpretable low-confidence patient profiles, and Detectron is then applied within each profile to test whether its degradation is associated with a detectable harmful covariate shift. Across three clinical prediction tasks and three injected subgroup shifts in MIMIC-IV, we find that shift detectability itself is informative. An injected age shift, undetectable at the population level, was nonetheless localized to specific degraded profiles, whereas sex- and race-related shifts were detected broadly and therefore offered little guidance for identifying the most affected patients.

0.47

FairGlucose: A CGM Fairness Benchmark Reveals Subgroup Disparities Hidden in Population-Level Validation

cs.CY cs.AI ·2026-08-18 ·Junjie Luo, Xuzhe Zhi, Rui Han, Abhimanyu Kumbara, Anand K. Iyer +3 more
benchmark similarity 0.62
Abstract

As CGM-based AI tools approach clinical deployment, whether their accuracy is equitable across patient demographics remains insufficiently tested. To enable this evaluation, we constructed FairGlucose, a 300-patient CGM cohort balanced across 12 demographic strata (age x gender x type 1/type 2 diabetes), with 132,480 forecasting samples and 3,945 unique behavioral events (meals, exercise, medication) logged by 81 patients. Benchmarking 33 models across four families on 2-hour glucose forecasting, we find that population-level external validation can conceal substantial subgroup disparities. Aggregate out-of-distribution metrics appear stable (approximately 1.0), yet subgroup-level ratios range from 0.8 to 1.4, with T1D patients showing 6 mg/dL higher prediction error than T2D (p < 0.001). This disparity persists across all 33 models, suggesting a property of the prediction task rather than any single architecture. Further analysis shows that subgroup performance gaps align with the proportion of clinically hard cases, and that input-length sensitivity varies across demographics, motivating personalized configurations. Frontier LLMs underperform specialized neural models by 1-6 mg/dL; behavioral events contribute negligibly (approximately 0.1 mg/dL) even under oracle event access. These findings establish that population-level validation alone is insufficient for equity assessment of digital health AI, motivating subgroup-disaggregated reporting as a default standard.

0.29

Attributing Cohen's d: Training Data Attribution for Disease-Related Effects in Normative Age Biomarkers

cs.LG q-bio.QM ·2026-09-07 ·Jakob Snel, Marc-Andre Schulz
similarity 0.61
Abstract

Normative age models are trained to predict chronological age in a nominally healthy cohort. Applied to patients, they deviate, and the gap between predicted and chronological age is read as disease risk. Here, we attribute the disease-related effect size of the age gap directly to individual training samples, rather than using a prediction-level loss as the attribution target. For Cohen's $d$, the resulting closed-form influence functional, validated against leave-one-out retraining, ranks training samples by their effect on held-out case-control separation. Across four diseases and two biomarker modalities in UK Biobank, removing the 10% most influential training samples raises held-out disease-related effect size in every seed. It more than doubles the metabolomic-age effect for type-2 diabetes and raises the brain-age effect for multiple sclerosis by roughly a third. Random removal leaves effect size flat even at 50% removal, confirming the gain comes from which samples are removed, not how many. Flagged subjects carry subclinical cardiometabolic burden that diagnosis-based exclusion misses, on markers the model never sees. For type-2 diabetes, where the method gains most, the marker recovered is HbA1c, the standard measure of blood sugar control. We release pyinfluence, our influence-function package, for reproducibility and reuse.

0.25

When uncertainty quantification fails: structural vulnerabilities and corrections for selective prediction under clinical class imbalance

cs.LG cs.AI ·2026-10-27 ·Walter Endrizzi, Flavio Ragni, Raffaele Marchesi, Stefano Bovo, Monica Moroni +2 more
code/data similarity 0.61
Abstract · https://github.com/endrwalter/uncertainty_ml

Background. Selective prediction systems improve the safety of clinical artificial intelligence by deferring ambiguous cases to human experts while automating high-confidence decisions. However, this safety mechanism relies entirely on the premise that uncertainty scores accurately reflect clinical ambiguity. In prognostic tasks characterized by severe class imbalance, where the clinical outcome of interest is a minority, this assumption breaks down. Standard uncertainty measures cease to capture clinically aligned ambiguity; instead, they become a proxy for class membership, systematically penalizing minority patients regardless of their individual predictive clarity. Results. Across 56 synthetic conditions and three neurodegenerative cohorts spanning severe class imbalance to near-balanced conditions (multiple sclerosis, Parkinson's Disease, Alzheimer's Disease), our framework consistently maintained bounded, balanced risk across trajectories. In contrast, global metrics either collapsed minority Sensitivity or protected the minority at the expense of majority patients. Applying CCR with standard entropy fails to protect the minority because it breaks within-class monotonicity when tau=0.5. Combining CCR with threshold-aware metrics restores strict monotonicity, correctly identifies ambiguous patients, and safely mitigates minority exclusion. Conclusions. Under clinical class imbalance, standard uncertainty quantification measures dataset sparsity rather than clinical ambiguity, creating a systemic illusion of safety. This bias is a correctable structural flaw. Clinical pipelines deploying selective prediction under imbalance should adopt threshold-aligned uncertainty measures and class-stratified evaluation. This reduces class-specific risk imbalance, supporting safer selective prediction under the evaluated conditions without silently excluding the most vulnerable patients.

0.31

Beyond Binary Classification: Multiclass Machine Learning for Diabetes and Prediabetes Risk Prediction Using NHANES

cs.LG ·2026-11-12 ·Aman Mujahid, Anita Penkova
similarity 0.61
Abstract

Detecting diabetes risk early is important for preventing disease progression. Most existing machine learning approaches focus on binary classification, which limits their ability to capture intermediate risk states such as prediabetes. We develop a supervised learning framework to classify adults as normal, prediabetic, or diabetic using National Health and Nutrition Examination Survey data. The framework uses routinely collected demographic, clinical, and lifestyle variables from 15,356 adults, with glycated hemoglobin (HbA1c) used only to define labels and excluded from input features to prevent leakage. We compare conventional machine learning and transformer-based models and examine two binary formulations: normal versus prediabetes, and normal versus combined prediabetes and diabetes. Models are evaluated on a held-out test set using precision, sensitivity, specificity, and F1 score. In the multiclass setting, performance is broadly consistent across models, with accuracy up to 0.72 and macro-averaged F1 of 0.70. Prediabetes remains the most challenging class, with F1 scores of 0.54 to 0.56 for conventional models and 0.53 to 0.55 for transformers, reflecting its overlap with both neighboring states. When the task is reduced to normal versus prediabetes, F1 scores rise modestly to 0.62 to 0.64. A more substantial improvement is observed under a broader screening formulation combining prediabetes and diabetes, with F1 scores of 0.73 to 0.74 across all models. These findings suggest that feature overlap along the biological continuum between normal and diabetic states contributes more to the difficulty of prediabetes detection than model architecture. Multiclass prediction provides a more clinically informative representation of metabolic risk progression but highlights a trade-off between clinically meaningful stratification and predictive accuracy.

0.18